Contineum Therapeutics, Inc.
CTNM
$9.80
-$0.59-5.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.31% | -9.78% | -41.86% | -13.96% | -7.03% |
| Total Depreciation and Amortization | 1.28% | 4.00% | 20.97% | 3.33% | -1.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.48% | 92.97% | -22.12% | 160.70% | 521.70% |
| Change in Net Operating Assets | -78.74% | -136.68% | 27.26% | 1,209.09% | -176.00% |
| Cash from Operations | -8.67% | -41.27% | -65.38% | 27.41% | -6.57% |
| Capital Expenditure | 6.38% | 71.69% | -102.44% | 31.09% | 19.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.91% | 262.24% | 69.38% | 22.33% | -536.81% |
| Cash from Investing | -6.91% | 258.87% | 68.90% | 22.41% | -545.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,012.50% | -96.26% | 4,838.46% | -99.99% | 88,608.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 200.00% |
| Cash from Financing | 279.17% | -96.26% | 4,838.46% | -99.99% | 602,122.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -419.92% | 102.78% | 47.86% | -159.61% | 8,160.98% |